Clinical Case Reports (Jan 2021)

Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease

  • Marianne E. M. Yee,
  • Glaivy Batsuli,
  • Satheesh Chonat,
  • Sunita Park

DOI
https://doi.org/10.1002/ccr3.3556
Journal volume & issue
Vol. 9, no. 1
pp. 457 – 460

Abstract

Read online

Abstract Thrombocytosis is common in sickle cell disease and may contribute to vaso‐occlusion. Hydroxyurea treats extreme thrombocytosis. Acquired von Willebrand disease should be considered prior to aspirin therapy.

Keywords